Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of UF-021 for Retinitis Pigmentosa
NCT01786395Phase 3Terminated
- Sponsor
- R-Tech Ueno
- Start
- Mar 2013
- Primary completion
- Apr 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of unoprostone isopropyl in retinitis pigmentosa (RP), sponsored by R-Tech Ueno. Started Mar 2013; status: terminated.
02
Drugs
unoprostone isopropyl
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT01786395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01786395.